IVA
Inventiva Sa
NASDAQ: IVA · HEALTHCARE · BIOTECHNOLOGY
$5.13
+3.85% today
Updated 2026-04-30
Market cap
$1.07B
P/E ratio
—
P/S ratio
157.56x
EPS (TTM)
$-2.23
Dividend yield
—
52W range
$3 – $8
Volume
0.4M
Inventiva Sa (IVA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-6,711.00%
ROE
-1,643.00%
ROA
-45.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $3.06M | $-7.13M | 45.11% | -406.81% | -232.82% |
| 2014 | $3.28M | $-7.49M | 53.59% | -410.22% | -228.26% |
| 2015 | $4.87M | $-8.82M | 71.18% | -318.17% | -181.00% |
| 2016 | $9.45M | $-7.05M | 84.27% | -137.83% | -74.59% |
| 2017 | $6.52M | $-17.23M | 81.05% | -320.76% | -264.22% |
| 2018 | $3.20M | $-33.62M | 69.75% | -1,040.13% | -1,051.49% |
| 2019 | $7.00M | $-30.22M | 100.00% | -433.15% | -431.85% |
| 2020 | $372000.00 | $-31.62M | 100.00% | -7,988.71% | -8,500.81% |
| 2021 | $4.19M | $-49.64M | 100.00% | -1,242.58% | -1,183.50% |
| 2022 | $12.18M | $-54.27M | 100.00% | -468.92% | -445.64% |
| 2023 | $17.48M | $-110.43M | 100.13% | -587.68% | -631.84% |
| 2024 | $9.20M | $-184.21M | 100.00% | -1,060.64% | -2,002.74% |
| 2025 | $4.48M | $-340.16M | 33.68% | -2,920.96% | -7,587.80% |